Item 8.01. Other Events.
On December 22, 2008, Avalon Pharmaceuticals, Inc., a Delaware corporation (the "Company") issued a press release announcing that the Company had received a letter from the The NASDAQ Stock Market, LLC notifying the Company that it had been granted an extension of time for compliance with NASDAQ Marketplace Rule 4450(a)(3). The press release is attached as Exhibit 99.1 hereto and is incorporated herein by reference.
Section 9 - Financial Statements and Exhibits Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
99.1 Press release dated December 22, 2008.

---